Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on "The Relationship Between Dose of Vitamin E and Suppression of Oxidative Stress in Humans"

Free Radical Biology and Medicine

Volumn 43, Issue 10, 2007, Pages 1374-1376

  Blumberg, Jeffrey B ^a   Frei, Balz ^b  

^a TUFTS UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; ISOPROSTANE DERIVATIVE;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RESEARCH; HEART PROTECTION; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIMARY PREVENTION; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

EID: 34948871565     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.08.017     Document Type: Note

References (15)

1. Greenberg E.R. Vitamin E supplements: Good in theory, but is the theory good?. Ann. Intern. Med. 142 (2005) 75-76
2. Roberts II L.J., Oates J.A., Linton M.F., Fazio S., Meador B.P., Gross M.D., Shyr U., and Morrow J.D. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic. Biol. Med. 43 (2007) 1388-1393
3. Sing U., Devaraj S., and Jialal I. Vitamin E, oxidative stress, and inflammation. Ann. Rev. Nutr. 25 (2005) 151-174
4. Knekt P., Ritz J., Pereira M.A., O'Reilly E.J., Augustsson K., Fraser G.E., Goldbourt U., Heitmann B.L., Hallmans G., Liu S., Pietinen P., Spiegelman D., Stevens J., Virtamo J., Willett W.C., Rimm E.B., and Ascherio A. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am. J. Clin. Nutr. 80 (2004) 1508-1520
5. Traber M.G. Heart disease and single-vitamin supplementation. Am. J. Clin. Nutr. 85 (2007) 293S-299S
6. Levine M., Wang Y., Padayatty S.J., and Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc. Natl. Acad. Sci. USA 98 (2001) 9842-9846
7. Cook N.R., Albert C.M., Gaziano J.M., Zaharris E., MacFadyen J., Danielson E., Buring J.E., and Manson J.E. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch. Intern. Med. 167 (2007) 1610-1618
8. Lee I.-M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., and Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer. The Women's Health Study: A randomized controlled trial. JAMA 294 (2005) 56-65
9. Leonard S.W., Good C.K., Gugger E.T., and Traber M.B. Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am. J. Clin. Nutr. 79 (2004) 86-92
10. Chiabrando C., Avanzini F., Rivalta C., Colombo F., Fanelli R., Palumbo G., and Roncaglioni M.C. PPP Collaborative Group on the antioxidant effect of vitamin E. Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors. Curr. Control Trials Cardiovasc. Med. 19 (2002) 5
11. Food and Nutrition Board, Institute of Medicine. Vitamin E. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids (2000), Natl. Acad. Press, Washington, DC 186-283
12. Dotan Y., Lichtenberg D., and Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog. Lipid Res. 43 (2004) 200-227
13. Mustacich D.J., Leonard S.W., Devereaux M.W., Sokol R.J., and Traber M.G. α-Tocopherol regulation of hepatic cytochrome P450s and ABC transporters. Free Radic. Biol. Med. 41 (2006) 1069-1078
14. Miller E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142 (2005) 37-46
15. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA 297 (2007) 842-857